Professor Arne Astrup is also involved in project to change widely-accepted definition of ultra-processed food ...

Denmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the ...

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

Morgan Stanley notes Novo Nordisk (NVO) disclosed headline data for CagriSema in REDEFINE-2, with a weight loss and safety profile similar to ...

Health-care companies fell as traders retreated from some of the highest risk issues.

Nvidia shares have been under pressure since late January, when the release of a lower cost artificial intelligence (AI) ...

Wilson Encourages Investors Who Suffered Losses In Novo Nordisk To Contact Him Directly To Discuss Their Options ...

In the trial, CagriSema appeared to have a safe and well-tolerated profile. The most common adverse events with CagriSema were gastrointestinal, and the vast majority were mild to moderate and ...

Roche (CH:ROG) shares rose as well, gaining 46in Zurich. Ozempic maker Novo Nordisk (DK:NOVO.B) (NVO), which along with Eli Lilly (LLY) dominates the weight-loss category, slumped 4%, though the ...

U.S. equities were mixed at midday as the markets weighed a better-than-expected report on inflation and more tariff news.

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Investing.com – Denmark stocks were lower after the close on Wednesday, as losses in the Healthcare, Personal & Household Goods ...